Latest Regulatory News

Toubani Resources has locked in a transformative A$395 million funding package to advance its Kobada Gold Project in Mali, setting the stage for production to commence by the third quarter of 2027.

Pacgold Limited’s trading suspension has been lifted following its announcement of a capital raising, signaling renewed market activity for the gold explorer.

NSX Limited shareholders overwhelmingly approved a scheme of arrangement for acquisition by 1001290557 Ontario Inc., a related entity of the Canadian Stock Exchange operator CNSX Markets Inc. The deal, valued at four cents per fully paid share, now awaits Federal Court approval to proceed.

DigitalX Limited reveals a robust A$101 million treasury portfolio dominated by Bitcoin holdings and a significant cash increase from Solana sales, underpinning its ambitious target of accumulating 2,100 Bitcoins by 2027.

Buru Energy secured key government approvals and identified a promising new gas prospect beneath its Rafael field, while raising $4.4 million to fund development activities. The company is gearing up for a Final Investment Decision in 3Q 2026, aiming for first material cash flow by 2028.

Triangle Energy and its joint venture partners have been awarded two offshore service contracts in the underexplored Sandakan Basin, Philippines, holding significant contingent gas and condensate resources. These contracts mark a strategic expansion into a promising region with multi-TCF exploration upside.

Kingsgate Consolidated updates its 2025 Mineral Resources and Ore Reserves, introducing a maiden estimate for the Chatree South-East Complex while reporting modest declines in overall Ore Reserves.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

Orthocell Limited has reported a record $3 million quarterly revenue, driven by strong sales of its nerve repair product Remplir in Australia and Singapore, while advancing its rollout in the US and Canada ahead of schedule.

Pacific Smiles Group has agreed to an unconditional $2.20 per share cash takeover offer from its majority shareholder Genesis Bidco, representing a 37.5% premium. The Independent Board Committee recommends shareholders accept the offer, pending no superior proposal and ongoing fairness confirmation.

CGN Resources has secured significant new gold tenements in Western Australia's Leonora district and advanced exploration at multiple projects, maintaining a solid cash position to support ongoing development.